Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteolipid protein 2 (PLP2) is an integral multi-pass membrane protein primarily localized to the endoplasmic reticulum of colonic epithelial cells, enriched especially in the colonic mucosa. It can multimerize, contains a MARVEL domain (often found in proteins involved in membrane apposition), and is proposed to function as an ion channel. PLP2 may play a role in cell differentiation within the intestinal epithelium, apoptosis, autophagy, inflammation, and other cellular processes. Increased PLP2 expression has been observed in several cancers and is associated with disease progression, particularly in high-grade gliomas where it serves as a prognostic marker. A promoter polymorphism may be linked to X-linked cognitive disability, and the gene has a pseudogene on chromosome 5. No approved pharmaceuticals are described as direct interactors, though its manipulation by genetic or pharmacological means has shown effects on cell death and tumor growth in research models.
No approved drugs targeting PLP2 directly; for research, knockdown increases ER stress-induced apoptosis and autophagy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteolipid protein 2 (PLP2).